CKD Research of Outcomes in Treatment and Epidemiology

CKD Research of Outcomes in Treatment and Epidemiology - CKD-ROUTE Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000004461

Enrollment

1000

Registered

2010-10-27

Start date

2010-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All new patients with non-dialysis CKD (stage 2, 3, 4 and 5) at the participating nephrology departments, who will likely to be followed by nephrologists for at least 1 year, and who provide written informed consent to participate in the present survey.

Exclusion criteria

Exclusion criteria: Cancer History of organ transplantation Active gastrointestinal bleeding

Design outcomes

Primary

Measure	Time frame
Decline in renal function defined by reduction in estimated GFR	—

Secondary

Measure	Time frame
Cardiovascular events Renal replacement therapy Death from cardiovascular events Death from any cause without accident Fractures (Fractures associated with major trauma, such as motor vehicle accidents are excluded.) Hospitalization Changes in the levels of WBC, Hb , Plt, TP, Alb, BUN, Cr, Na, K, Cl, Ca, P, Alp, T-Chol, TG, HDL, CK, Glu, HbA1c, Fe, UIBC (or TIBC), ferritin, CRP, intact PTH. Changes in the levels of urinary protein and urinary blood Changes in blood pressure Changes in the values of body weight and BMI	—

Measure

Time frame

Cardiovascular events Renal replacement therapy Death from cardiovascular events Death from any cause without accident Fractures (Fractures associated with major trauma, such as motor vehicle accidents are excluded.) Hospitalization Changes in the levels of WBC, Hb , Plt, TP, Alb, BUN, Cr, Na, K, Cl, Ca, P, Alp, T-Chol, TG, HDL, CK, Glu, HbA1c, Fe, UIBC (or TIBC), ferritin, CRP, intact PTH. Changes in the levels of urinary protein and urinary blood Changes in blood pressure Changes in the values of body weight and BMI

—

Countries

Japan

Contacts

Public ContactYumi Noda

Tokyo Medical and Dental University Department of Chronic Kidney Disease

ynodmed2@tmd.ac.jp03-5803-5214

Outcome results